Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 49 min ago
Peer-reviewedCC BYCureus

Biopsy-Proven Glomerular Diseases in Saudi Arabia: The Clinicopathological Spectrum and Predictors of Renal Outcomes in a Single-Center Cohort and Four Decades of National Data

  • Hassan M Homadi1
  • Muhammad Abdul Mabood Khalil1
  • Nihal M Sadagah1
  • Hinda Hassan Mahmood1
  • Abeer A AlMarhabi2
  • Alfatih A Altom1
  • Turki A Hamdi2
  • Ammar T Elgadi3
  • Nadin A Alharbi2
  • Bodoor Alahmadi2
  • Wafaa M Alalyani2
  • Salem Al-Qurashi1
  1. 1Renal Diseases and Transplantation Centre, King Fahad Armed Forces Hospital, Jeddah, SAU
  2. 2Department of Medicine, King Fahad Armed Forces Hospital, Jeddah, SAU
  3. 3Faculty of Medicine, University of Khartoum, Khartoum, SDN
Read full textPDFCite

Related

  1. Glomerular diseases associated with multiple myeloma: renal pathology and survival outcomes in a retrospective study at Charles Nicolle Hospital, Tunis, Tunisia.
    Meriam Hajji, Samia Barbouch, Seif Azaiez +5
    The Pan African medical journalPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  2. Spatially resolved transcriptomics of glomerular diseases
    T. Shin, S. Weissbach, P. Capodieci +14
    medRxivPreprintAll rights reservedFull textGeneral medicinemedRxiv
  3. Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases
    Brendon Lange Neuen, Vlado Perkovic, Rajiv Agarwal +97
    JAMAPeer-reviewedLicence not statedFull text13 citedGeneral medicineOpenAlex
  4. Clinicopathological predictors and an internally validated exploratory nomogram for 2-year recurrence after hepatic resection of hepatocellular carcinoma ≤5 cm.
    Wei Zhang, Yubo Zhang, Qi Wang +3
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Switching Beyond Rituximab in Primary Glomerular Diseases: A Systematic Review of Within-Patient Efficacy and Safety of Non-Rituximab Anti-CD20 Antibodies.
    Francesca K Martino, Lucia F Stefanelli, Leda Cattarin +3
    Antibodies (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{homadi2026biopsyproven,
  title = {{Biopsy-Proven Glomerular Diseases in Saudi Arabia: The Clinicopathological Spectrum and Predictors of Renal Outcomes in a Single-Center Cohort and Four Decades of National Data}},
  author = {Hassan M Homadi and Muhammad Abdul Mabood Khalil and Nihal M Sadagah and Hinda Hassan Mahmood and Abeer A AlMarhabi and Alfatih A Altom and Turki A Hamdi and Ammar T Elgadi and Nadin A Alharbi and Bodoor Alahmadi and Wafaa M Alalyani and Salem Al-Qurashi},
  journal = {Cureus},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13676788},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Biopsy-Proven Glomerular Diseases in Saudi Arabia: The Clinicopathological Spectrum and Predictors of Renal Outcomes in a Single-Center Cohort and Four Decades of National Data
AU  - Hassan M Homadi
AU  - Muhammad Abdul Mabood Khalil
AU  - Nihal M Sadagah
AU  - Hinda Hassan Mahmood
AU  - Abeer A AlMarhabi
AU  - Alfatih A Altom
AU  - Turki A Hamdi
AU  - Ammar T Elgadi
AU  - Nadin A Alharbi
AU  - Bodoor Alahmadi
AU  - Wafaa M Alalyani
AU  - Salem Al-Qurashi
PY  - 2026
DA  - 2026/10/19
JO  - Cureus
UR  - https://europepmc.org/article/PMC/PMC13676788
SN  - 2168-8184
ER  -